# VERVE THERAPEUTICS INC (VERV)

> Institutional ownership reported to the SEC as of Q4 2025, from Form 13F filings. Source: https://holderbook.com/stocks/VERV/

- Reporting holders: 1
- Reported value: $344.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DekaBank Deutsche Girozentrale](https://holderbook.com/funds/1456228-dekabank-deutsche-girozentrale/) | $344.0K | 24,000 | 0.0% | 14 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2025 | 1 | $344.0K |
| Q3 2025 | 6 | $1.4M |
| Q2 2025 | 175 | $867.7M |
| Q1 2025 | 191 | $371.4M |
| Q4 2024 | 166 | $446.6M |
| Q3 2024 | 172 | $375.2M |
| Q2 2024 | 164 | $382.3M |
| Q1 2024 | 162 | $1.1B |
| Q4 2023 | 158 | $1.1B |
| Q3 2023 | 136 | $859.2M |
| Q2 2023 | 121 | $1.2B |
| Q1 2023 | 125 | $1.0B |